JP2025504916A5 - - Google Patents
Info
- Publication number
- JP2025504916A5 JP2025504916A5 JP2024544446A JP2024544446A JP2025504916A5 JP 2025504916 A5 JP2025504916 A5 JP 2025504916A5 JP 2024544446 A JP2024544446 A JP 2024544446A JP 2024544446 A JP2024544446 A JP 2024544446A JP 2025504916 A5 JP2025504916 A5 JP 2025504916A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- group
- compound according
- ring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263303368P | 2022-01-26 | 2022-01-26 | |
| US63/303,368 | 2022-01-26 | ||
| US202263435212P | 2022-12-23 | 2022-12-23 | |
| US63/435,212 | 2022-12-23 | ||
| PCT/US2023/011659 WO2023146990A1 (en) | 2022-01-26 | 2023-01-26 | Compounds and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025504916A JP2025504916A (ja) | 2025-02-19 |
| JP2025504916A5 true JP2025504916A5 (https=) | 2026-02-16 |
Family
ID=85383019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024544446A Pending JP2025504916A (ja) | 2022-01-26 | 2023-01-26 | 化合物及び使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250163048A1 (https=) |
| EP (1) | EP4469455A1 (https=) |
| JP (1) | JP2025504916A (https=) |
| TW (1) | TW202339737A (https=) |
| WO (1) | WO2023146990A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119744263A (zh) * | 2022-08-19 | 2025-04-01 | 北京望实智慧科技有限公司 | Prmt5抑制剂 |
| CN120476118A (zh) * | 2023-01-17 | 2025-08-12 | 苏州浦合医药科技有限公司 | Prmt5-mta抑制剂 |
| CN120457129A (zh) * | 2023-01-31 | 2025-08-08 | 四川科伦博泰生物医药股份有限公司 | 草酸二酰胺化合物、包含其的药物组合物及其制备方法和用途 |
| WO2025217297A1 (en) | 2024-04-09 | 2025-10-16 | Tango Therapeutics, Inc. | Prmt5 inhibitors for use in methods of treating mta-accumulating cancer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
| WO2011079236A1 (en) | 2009-12-22 | 2011-06-30 | The Ohio State University Research Foundation | Compositions and methods for cancer detection and treatment |
| WO2021004547A1 (en) * | 2019-07-11 | 2021-01-14 | Guangdong Newopp Biopharmaceuticals Co., Ltd. | Heterocyclic compounds as inhibitors of hpk1 |
| WO2022026892A1 (en) * | 2020-07-31 | 2022-02-03 | Tango Therapeutics, Inc. | Piperidin-1- yl-n-pyrydi ne-3-yl-2-oxoacet am ide derivatives useful for the treatment of mtap-deficient and/or mt a-accumulating cancers |
-
2023
- 2023-01-26 JP JP2024544446A patent/JP2025504916A/ja active Pending
- 2023-01-26 WO PCT/US2023/011659 patent/WO2023146990A1/en not_active Ceased
- 2023-01-26 US US18/833,319 patent/US20250163048A1/en active Pending
- 2023-01-26 EP EP23707537.9A patent/EP4469455A1/en active Pending
- 2023-01-30 TW TW112103171A patent/TW202339737A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025504916A5 (https=) | ||
| RU2650895C2 (ru) | Соединения замещенных пиразолонов и способы использования | |
| JP5939254B2 (ja) | ｃ−Ｍｅｔキナーゼ阻害剤としての化合物 | |
| JP6581320B2 (ja) | 腫瘍治療用医薬組成物 | |
| CA3208313A1 (en) | Isoindolinone compounds | |
| JP2010539110A5 (https=) | ||
| JP2018507877A5 (https=) | ||
| WO2018057973A4 (en) | Compounds and methods for ido and tdo modulation, and indications therefor | |
| JP2010265302A5 (https=) | ||
| MX2013002431A (es) | Nuevos compuestos y composiciones para la inhibicion de nampt. | |
| RU2013154117A (ru) | Производные 1-фенил-2-пиридинилалкильных спиртов в качестве ингибиторов фосфодиэстеразы | |
| JP2014518544A5 (https=) | ||
| JP2017530185A5 (https=) | ||
| EA023420B1 (ru) | Замещенные имидазопиридазины | |
| RU2017111200A (ru) | Циклогексилэтилзамещенные диаза- и триаза-трициклические соединения в качестве антагонистов индоламин-2,3-диоксигеназы для лечения рака | |
| JP2018501315A5 (https=) | ||
| JP2010528021A5 (https=) | ||
| JP2018500342A (ja) | トリアゾロピリミジン化合物およびその使用 | |
| KR20130129244A (ko) | 치환된 6,6-융합된 질소 헤테로환형 화합물 및 이의 용도 | |
| HRP20201469T1 (hr) | Derivati tetrahidroizokinolina | |
| JP2009513703A5 (https=) | ||
| JP2017537948A5 (https=) | ||
| RU2013144571A (ru) | Алинзамещенные хиназолины и способы их применения | |
| JP2017537111A (ja) | ヘテロ環式誘導体およびその使用 | |
| EP4323349A1 (en) | Isoindolinone amide compounds useful to treat diseases associated with gspt1 |